About Lodestone Biomedical
Lodestone Biomedical is a company based in Hanover (United States) founded in 2015 by Lidia Valdes. Lodestone Biomedical has raised $1.19 million across 5 funding rounds from investors including MassChallenge. Lodestone Biomedical operates in a competitive market with competitors including BioImage, BioAmp Diagnostics, ACS Biomarker, Araceli Biosciences and HAWK Biosystems, among others.
- Headquarter Hanover, United States
- Founders Lidia Valdes
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
$957.21 K (USD)103as on Dec 31, 2023
-
Net Profit
-$59.27 K (USD)67as on Dec 31, 2023
-
EBITDA
Not available
-
Total Equity Funding
$1.19 M (USD)
in 5 rounds
-
Latest Funding Round
$75 K (USD), Seed
Jun 29, 2025
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Lodestone Biomedical
Lodestone Biomedical has successfully raised a total of $1.19M across 5 strategic funding rounds. The most recent funding activity was a Seed round of $75 thousand completed in June 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Lodestone Biomedical
Lodestone Biomedical has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include MassChallenge.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage entrepreneurs are accelerated through MassChallenge's program.
|
Locked | Locked | Locked |
Investor details for Lodestone Biomedical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Lodestone Biomedical
Investment portfolio details for Lodestone Biomedical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Lodestone Biomedical
Detailed financials for Lodestone Biomedical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lodestone Biomedical Comparisons
Peer comparison for Lodestone Biomedical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Lodestone Biomedical
Lodestone Biomedical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioImage, BioAmp Diagnostics, ACS Biomarker, Araceli Biosciences and HAWK Biosystems, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Bioassays are developed for biopharmaceutical firms and research organizations.
|
|
| Locked | Locked | Locked |
Developers of diagnostic tests that help to treat patient with a specific antibiotic
|
|
| Locked | Locked | Locked |
Novel biomarkers for cardiac disease are discovered, validated, and commercialized.
|
|
| Locked | Locked | Locked |
Scientific tools for tissue and cell-based biomarker discovery are developed.
|
|
| Locked | Locked | Locked |
Clinical assays are developed for quantifying novel biomarkers in samples.
|
Detailed competitors of Lodestone Biomedical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lodestone Biomedical
Complete news archive for Lodestone Biomedical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lodestone Biomedical
Lodestone Biomedical was founded in 2015.
Lodestone Biomedical is headquartered in Hanover, United States. It is registered at Hanover, New Hampshire, United States.
Lidia Valdes is the current CEO of Lodestone Biomedical. They have also founded this company.
Lodestone Biomedical is a funded company, having raised a total of $1.19M across 5 funding rounds to date.
Annual revenue of Lodestone Biomedical is $957.21K as on Dec 31, 2023.
Lodestone Biomedical was founded in 2015 in Hanover, United States, as a provider of magnetic nanoparticle platform technology focused on immuno-oncology. The Immunotherapy Response Indication System (IRIS) is utilized to interrogate binding states of functionalized magnetic nanoparticles in needle-implantable biosensor probes. Real-time signals of treatment efficacy and response are monitored within the tumor-immune microenvironment. Operations center on in vivo biomarker detection for clinical applications.
Lodestone Biomedical's top competitors include Araceli Biosciences, BioAmp Diagnostics and BioImage.
Lodestone Biomedical has 1 investor. Key investors include MassChallenge.